- Scrip Originals
Brought to you by
Kaleido Biosciences goes public netting $69.8mm
04 Mar 2019
Kaleido Biosciences Inc. netted $69.8mm in its initial public offering of 5mm common shares at $15 each on the Nasdaq. The company had planned to sell 4.76mm shares between $20 and $22.
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com